The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Roberts Margo R since 2015.
The trader's CIK number is 1609643.
At the time of the last reporting, Roberts Margo R was the Chief Scientific Officer of Kite Pharma, Inc.. (stock ticker symbol KITE).
Also see all insider trading activities at Kite Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | KITE | 0 | $0 | 33,401 | $1,937,747 | 33,401 | $142,786 |
| 2015 | KITE | 0 | $0 | 70,142 | $4,546,731 | 70,142 | $480,166 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-03-15 | KITE | Sale | 8,506 | 46.40 | 394,703 |
| 2016-03-15 | KITE | Option Ex | 8,506 | 8.85 | 75,278 |
| 2016-02-12 | KITE | Option Ex | 18,750 | .70 | 13,125 |
| 2016-02-12 | KITE | Sale | 18,750 | 64.16 | 1,202,962 |
| 2016-01-15 | KITE | Sale | 6,145 | 55.34 | 340,082 |
| 2016-01-15 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-12-15 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-12-15 | KITE | Sale | 6,145 | 64.00 | 393,280 |
| 2015-11-16 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-11-16 | KITE | Sale | 6,145 | 78.26 | 480,907 |
| 2015-10-15 | KITE | Sale | 6,145 | 62.47 | 383,865 |
| 2015-10-15 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-09-15 | KITE | Sale | 6,145 | 64.32 | 395,246 |
| 2015-09-15 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-08-17 | KITE | Option Ex | 6,145 | 8.85 | 54,383 |
| 2015-08-17 | KITE | Sale | 6,145 | 60.93 | 374,414 |
| 2015-07-15 | KITE | Sale | 22,167 | 71.66 | 1,588,442 |
| 2015-07-15 | KITE | Option Ex | 22,167 | 8.85 | 196,177 |
| 2015-06-15 | KITE | Option Ex | 8,625 | .70 | 6,037 |
| 2015-06-15 | KITE | Sale | 8,625 | 56.97 | 491,392 |
| 2015-05-15 | KITE | Option Ex | 8,625 | .70 | 6,037 |
| 2015-05-15 | KITE | Sale | 8,625 | 50.92 | 439,185 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts Margo R (Chief Scientific Officer of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.